Pilot Teal Health’s at-home screening to:

INCREASE HEDIS SCORE

Don’t let your patients fall behind. 94% of women prefer the Teal Wand to the current screening experience. Improve your screening rates and HEDIS score without spending more on resources.

SAVE TIME FOR PROVIDERS

With patients screening beforehand, at home, providers have more time to address additional patient needs and conduct other valuable tests.

ADDRESS HEALTH INEQUITIES

35-44 year olds, Hispanic, and Black women are impacted by cervical cancer at higher rates than most.2,3 With the Teal Wand, you can engage these populations in screening and follow-up care.

YOUR PATIENTS & PROVIDERS WILL THANK YOU

With the Teal Wand, you could see a nearly 20% increased screening rate across race and ethnicity

1 in 4 U.S. women are not up-to-date on their cervical cancer screening.4 On average, 86% said they would stay up-to-date on screening if the Teal Wand was available.

See Teal Health’s Research

“Women want more convenient healthcare options that are under their control. Like colon cancer screening, we have the ability to increase access and improve the screening experience, without adding stress to the health system.”

Kara Egan, CEO and Co-Founder of Teal Health

DELIVER AN EXPERIENCE DESIGNED FOR WOMEN

Convenience and experience are important

70%

Although consumers are generally inclined to stay with their current primary care provider, up to 70% are open to changing if the alternative offers meaningful differentiation.5

60%

Of consumers reported being more satisfied with their recent telehealth appointment than with an in-person appointment.5

50%

Of consumers take advantage of multimodal care: for example, nearly half of OBGYN telehealth visits are followed up with an in-person appointment.5

SELF-COLLECT CAN IMPROVE FOLLOW-UP ADHERENCE

Research shows self-collect leads to higher rates of follow-up care - as high as 85-94%6, compared to 50% today7

Teal Health for Health Systems

Let’s assemble a partnership that will satisfy your care measures and help you reach your goals.

Run a pilot program with underscreened patients

+

Women aged 35-44 years are most frequently diagnosed with cervical cancer. Moreover, Hispanic, Black, and Native American women are impacted at higher rates. That's over one third of the US female population. With the Teal Wand, you can engage more of these populations in routine screening and follow-up healthcare.

We can work with you to establish kit mailing programs, targeting your underscreened patients.

Refer patients for at-home screening

+

Whether we establish a larger screening program or handle screening requests individually, Teal Health has the infrastructure in place to ensure patients complete eligibility, receive their screening kit and their results, and have access to medical providers virtually.

Co-market on educational screening campaigns

+

Per a 2024 McKinsey report, “Consumers are most receptive to receiving information when learning about their health and managing their health at home.”

There is a lot of confusion around cervical cancer screenings among patients and your health system has a lot of initiatives they need to focus on throughout the year. Fortunately, the Teal marketing team is dedicated to cervical cancer screenings and can assist you in compiling the necessary materials and campaigns to co-educate your patients on their screening options and empower them to take a more active role in managing their health.

How at-home screening works

1

Kit is prescribed and shipped to the patient’s home. They collect a sample for HPV testing.

2

Patient mails sample to lab and receive results in secure Teal account within a week.

3

If needed, patient can connect virtually with a Teal provider and be referred to the health system for follow-up care.

Request a kit and attend a short visit* with a Teal provider to learn about screening at home.

1

Receive your kit, comfortably collect your sample, and mail it to the lab.

2

View results in your Teal patient portal and connect virtually with a Teal provider, if follow-up is needed.

3

*The Teal Wand requires a prescription, so a short virtual visit with a Teal provider is needed before we can mail your kit. We'll review your past screenings and discuss the at-home screening process.

Interested in a screening pilot?

Let’s work together to increase access and improve the cervical cancer screening experience

Book a Demo

Backed by a rigorous clinical trial with the leading experts and organizations in healthcare

See Clinical Trial Details
Ann S. Collins, MD, FACOG
OB/GYN

Centre Obstetrics and Gynecology
Christine Conageski, MD, MSc
OB/GYN and Associate Professor
Elizabeth Sutton PhD
Director of Scientific Research

Woman's Hospital
Ronald W. Orso, MD
OB/GYN

Birmingham Obstetrics &
Gynecology, P.C.
Catherine Behrens, MD, PhD, FACOG
OB/GYN and Clinical Development
Advisor
Emeline Aviki, MD, MBA
Medical Director, Network Integration
and Strategy & Gynecologic
Oncologist
Sangini S. Sheth, MD, MPH, FACOG
Associate Professor of Obstetrics,
Gynecology & Reproductive Sciences
Summer Dewdney, MD
Gynecologic Oncologist

Your experience matters

Signup to be the first to know when we’re available in your state.

Thank you!
Your submission has been received!
Oops! Something went wrong while submitting the form.
Sources

1https://www.getteal.com/research/u-s-clinical-study-demonstrates-94-of-women-prefer-at-home-cervical-cancer-screening
2https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html
3https://progressreport.cancer.gov/detection/cervical_cancer#field_measure
4Healthy People 2030, U.S. cervical cancer screening rates
5https://www.mckinsey.com/industries/healthcare/our-insights/consumers-rule-driving-healthcare-growth-with-a-consumer-led-strategy
6https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/screening-tests/hpv-test.html
7https://pubmed.ncbi.nlm.nih.gov/29686981/
8https://www.mckinsey.com/industries/healthcare/our-insights/health-media-how-consumer-content-informs-the-future-of-healthcare

LBL-040 Rev 0